Nanocovax

· Nanogen Pharmaceutical Biotechnology Joint Stock Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Nanocovax, covering 2020-12-29 to 2025-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19 [Phase 3]